Drug Screening Market Trends 2026–2031: Chromatography and Mass Spectrometry Held a 44.77% Share in 2025 Amid Growing Demand for Advanced Testing, Reports Mordor Intelligence
The global drug screening market is projected to reach USD 20.86 billion by 2031, growing at a CAGR of 16.16%, with Asia-Pacific emerging as the fastest-growing region, driven by expanding healthcare infrastructure and rising drug abuse monitoring initiatives.
Hyderabad, April 03, 2026 (GLOBE NEWSWIRE) — According to Mordor Intelligence, the drug screening market size was valued at USD 8.49 billion in 2025 and is projected to grow from USD 9.86 billion in 2026 to approximately USD 20.86 billion by 2031, registering a CAGR of 16.16% during the forecast period (2026–2031). By technology, chromatography and mass spectrometry held a 44.77% share in 2025, reflecting strong adoption of advanced analytical techniques. Overall market growth is driven by increasing adoption of drug testing across workplaces, healthcare settings, and law enforcement agencies, alongside rising concerns over substance abuse and the enforcement of stringent regulatory and safety standards worldwide.
Employers and healthcare providers are increasingly utilizing drug screening to ensure safety, maintain compliance, and support public health initiatives. The expanding use of screening in pre-employment testing, random testing programs, and post-incident investigations is further contributing to market demand. Technological advancements are playing a key role in market expansion, with the development of advanced immunoassay analyzers, chromatography techniques, and point-of-care testing devices improving detection accuracy and turnaround times. Rapid test kits and portable screening devices are gaining traction due to their convenience and ability to deliver real-time results in decentralized settings. Additionally, increasing awareness of substance abuse and growing government initiatives aimed at prevention and control are supporting continued market growth.
Drug Screening Market Share by Region
Asia-Pacific is emerging as a high-growth region due to expanding industrial sectors, increasing adoption of workplace safety standards, and growing awareness of drug testing across countries such as China, India, and Japan.
Europe holds a notable position in the market, supported by regulatory frameworks, increasing workplace safety initiatives, and rising awareness regarding substance abuse prevention.
North America represents a significant share of the drug screening market, driven by strict workplace regulations, high adoption of drug testing programs, and advanced healthcare infrastructure. The region continues to lead in the implementation of comprehensive screening policies.
Drug Screening Market Trends & Forecast
Rising Adoption of Point-of-Care Drug Testing
Point-of-care testing solutions are gaining popularity due to their ability to provide rapid and on-site results, improving efficiency in workplace and clinical settings.
Increasing Focus on Workplace Safety and Compliance
Organizations are strengthening drug screening programs to ensure compliance with safety regulations and reduce risks associated with substance abuse in the workplace.
Drug Screening Market Segmentation Overview
By Product & Service
- Consumables
- Instruments
- Rapid Testing Devices
- Services
By Technology
- Immunoassay
- Chromatography & Mass-Spectrometry
- Breath Analysers
- Others
By Sample Type
- Urine
- Oral Fluid
- Hair
- Other Samples
By Testing Setting
- Workplace
- Criminal Justice & Law Enforcement
- Pain Management & Opioid Monitoring
- Drug Treatment & Rehabilitation
By End User
- Drug Testing Laboratories
- Hospitals & Clinics
- Home & OTC
- Others
By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
- South America
- Brazil
- Argentina
- Rest of South America
For a full breakdown of market dynamics, segmentation insights, regional analysis, and competitive landscape, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/drug-screening-market?utm_source=globenewswire
Soumya Goud, Senior Research Manager, Mordor Intelligence, says, “The drug screening market reflects sustained demand linked to workplace policies, healthcare protocols, and regulatory oversight, with adoption patterns varying across regions and end users. Mordor Intelligence’s careful source validation and consistent review framework provide dependable, audit-ready insights for informed decision-making.”
Drug Screening Market Competitive Outlook
The drug screening market features a mix of global diagnostics companies and specialized testing solution providers focusing on innovation, accuracy, and rapid detection capabilities. Market participants are investing in advanced technologies, expanding product portfolios, and strengthening distribution networks to meet the growing demand for drug testing solutions across multiple sectors.
Major Companies include:
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Siemens Healthineers AG
- Bio-Rad Laboratories, Inc.
- Quest Diagnostics Incorporated
- Laboratory Corporation of America Holdings
- OraSure Technologies, Inc.
- Drägerwerk AG & Co. KGaA
- Omega Laboratories, Inc.
Check out related reports published by Mordor Intelligence:
Sepsis Diagnostics Market Size – The sepsis diagnostics market is estimated at USD 0.79 billion in 2025 and is projected to reach USD 1.08 billion by 2030, registering a CAGR of 6.58% during the forecast period. Growth is driven by increasing incidence of sepsis, rising demand for rapid diagnostic testing, and growing adoption of advanced molecular and biomarker-based diagnostic technologies.
Abbott, Diasorin, Becton, Dickinson, and Company, bioMérieux SA and F. Hoffmann-LA Roche Ltd are the major companies operating in this market.
Read more about companies in the sepsis diagnostics market: https://www.mordorintelligence.com/industry-reports/sepsis-diagnostics-market/companies?utm_source=globenewswire
Non-Invasive Prenatal Testing Market Share – The non-invasive prenatal testing market is estimated to grow from USD 4.43 billion in 2026 to USD 8.36 billion by 2031, registering a CAGR of 13.53% during the forecast period. Market expansion is supported by increasing maternal age, rising awareness of early genetic screening, and growing adoption of non-invasive diagnostic techniques in prenatal care.
Blood Glucose Monitoring Market Trends – The blood glucose monitoring market is estimated at USD 26.51 billion in 2026 and is projected to reach USD 38.87 billion by 2031, growing at a CAGR of 7.95%. Growth is driven by the rising prevalence of diabetes, increasing adoption of continuous glucose monitoring systems, and growing demand for home-based monitoring solutions.
About Mordor Intelligence
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape.
This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, and logistics.
CONTACT: For any inquiries, please contact: [email protected] https://www.mordorintelligence.com/contact-us
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.
